相关实验视频

Updated: Jul 5, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

血清胰岛素样生长因子结合蛋白-2作为COVID-19严重程度的预后因素

Patricia Mester¹, Ulrich Räth¹, Stephan Schmid¹

¹Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.

|January 23, 2024

概括

胰岛素样生长因子结合蛋白 (IGFBP) - 2水平升高表明严重的COVID-19疾病,而不仅仅是感染. 较高的IGFBP-2与危急疾病,血管压缩剂的使用和COVID-19患者的较差结果相关.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
关键护理医学关键护理医学

背景情况:

胰岛素类生长因子结合蛋白 (IGFBP) - 2 调节合成代谢途径,在严重疾病期间经常被禁用.
了解IGFBP-2在严重疾病,特别是COVID-19中的作用,对于评估疾病严重程度至关重要.

研究的目的:

测量COVID-19患者中度和重度疾病的血清IGFBP-2水平.
为了确定血清IGFBP-2水平和COVID-19疾病严重程度之间的关联.

主要方法:

从COVID-19患者 (中度和重度) 和健康对照组中收集了血清样本.
血清IGFBP-2水平被量化并在不同组之间进行了比较.
分析了与血管压缩剂使用和前素等临床参数的相关性.

主要成果:

严重的COVID-19患者的血清IGFBP-2水平明显高于中度病例和健康对照.
升高的IGFBP-2水平与需要透析和血管压缩剂治疗有关.
血清IGFBP-2与前素水平呈正相关性.

结论:

高血清IGFBP-2水平与COVID-19疾病严重程度的增加有关.
升高的IGFBP-2似乎是危急疾病的标志物,而不是SARS-CoV-2感染本身.
在COVID-19患者中,IGFBP-2可能作为危急疾病的潜在生物标志物.

关键词:

在 COVID-19 疫情中,在 IGFBP-2 中.重症监护室的重症监护室是重症监护室的重症监护室.死亡率死亡率这是什么意思? procalcitonin.预后预后预后

更多相关视频

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...